HIGHLIGHTS
- who: Dissanayake P. et al. from the Diabetes and Endocrinology Unit, National Hospital of Sri Lanka have published the article: Use of sulphonylurea in type 2 diabetes mellitus and incident risk of Hepatocellular Carcinoma : Are we safe to prescribe?, in the Journal: (JOURNAL)
- what: Metformin and TZDs have beneficial effects on HCC incidence.
SUMMARY
Incidence rate and mortality rates are roughly being comparable. For example; in 2018, the estimated Worldwide there is an exponential rise in the global incidence rate of HCC per 100,000 incidence as well as the mortality . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.